EdGene BioMed - About the company
EdGene BioMed is an unfunded company based in Gurugram (India), founded in 2018. It operates as a Provider of AI-driven bioinformatics solutions for disease diagnostics and personalized care. EdGene BioMed has not raised any funding yet. The company has 722 active competitors, including 72 funded and 67 that have exited. Its top competitors include companies like Strand Life Sciences, BGI and Hexagon Bio.
Company Details
Provider of AI-driven bioinformatics solutions for disease diagnostics and personalized care. It specializes in creating AI-driven tools for precise disease diagnostics, biomarker identification, and patient-centric care. The company offers GenAI services, AI integration into existing analysis pipelines, and development of automated bioinformatics data analysis pipelines. It also provides customized bioinformatics computer systems and technical assistance.
- Website
- edgenebiomed.com
- Social
- Email ID
- *****@edgenebiomed.com
- Phone Number
- +91 **********
- Registered Address
- House No. 200, 8 Marla, Radha Krishan Mandir, Panipat, Panipat, Haryana, India, 132103
Key Metrics
Founded Year
2018
Location
Gurugram, India
Stage
Unfunded
Ranked
256th among 722 active competitors
Annual Revenue
0 - ₹10 Cr as on Mar 31, 2025
Employee Count
1 as on Jul 31, 2026
Similar Companies
Legal entities associated with EdGene BioMed
EdGene BioMed is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
EDGENE BIOMED PRIVATE LIMITED CIN: U74999HR2018PTC072460 , India, Active | Feb 02, 2018 | 0 - ₹10 Cr (As on Mar 31, 2025) | - |
Sign up to download EdGene BioMed's company profile
EdGene BioMed's funding and investors
EdGene BioMed has not raised any funding rounds yet.
EdGene BioMed's founders and board of directors
Founder? Claim ProfileEdGene BioMed's Board of Directors
EdGene BioMed's board has 2 active members. Yash Shrivastava is part of team and Vandana Shrivastava is independent board member.Here is the list of EdGene BioMed's board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 1y 9m | |
Independent board member | - | Current | 3y 3m |
EdGene BioMed's employee count trend
EdGene BioMed has 1 employees as of Jul 26. Here is EdGene BioMed's employee count trend over the years:
Uncover EdGene BioMed's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
EdGene BioMed's Competitors and alternates
Top competitors of EdGene BioMed include Strand Life Sciences, BGI and Hexagon Bio. Here is the list of Top 10 competitors of EdGene BioMed, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Strand Life Sciences 2000, Bengaluru (India), Acquired | Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery | $34.9M | 74/100 | |
2nd | Provider of services in genome sequencing | - | 64/100 | ||
3rd | Hexagon Bio 2017, Menlo Park (United States), Series B | Provider of bioinformatics tools for the analysis of microbial genomic sequencing data | $206M | 62/100 | |
4th |  Cellanome 2020, Palo Alto (United States), Series B | Developer of the omic data platform for researchers | $119M | 59/100 | |
5th |  Enara Bio 2016, Oxford (United Kingdom), Series B | Developer of T-cell based cancer-cell interface for therapeutics | $84.1M | 53/100 | |
6th | Provider of genomic DNA tests for assessing predisposition to diseases & personalized nutrition | $1.81M | 52/100 | ||
7th | Berry Genomics 2010, Beijing (China), Public | Provider of genetic testing products and tests | $16M | 50/100 | |
8th | Provider of services for research application across life sciences industries | - | 49/100 | ||
9th | AI-based oncology therapy plan solution for professionals | $43M | 49/100 | ||
10th |  Amplia Therapeutics 2000, North Melbourne (Australia), Public | Developer of therapies for treating cancer and pulmonary fibrosis | - | - | 47/100 |
256th |  EdGene BioMed 2018, Gurugram (India), Unfunded | Provider of AI-driven bioinformatics solutions for disease diagnostics and personalized care | - | - | 27/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on EdGene BioMed's competitors? Click here to see the top ones
EdGene BioMed's Investments and acquisitions
EdGene BioMed has made no investments or acquisitions yet.
Reports related to EdGene BioMed
Here is the latest report on EdGene BioMed's sector:
Are you a Founder ?
FAQs about EdGene BioMed
Explore our recently published companies
- Sabarigiri English School - India based, Unfunded company
- Lara Morgan - United Kingdom based, Unfunded company
- Mystiq Extensions - Airdrie based, Unfunded company
- DPGA - India based, Unfunded company
- April Sheerin - Derry based, 1998 founded, Unfunded company
- DELIGHT MEDIA AND - India based, 2010 founded, Unfunded company
